Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2026)

Eton Pharmaceuticals has disclosed Asset Utilization Ratio across 7 years of filings, most recently posting 0.96 for Q2 2026.

• In Q2 2026, Asset Utilization Ratio rose 53.91% year-over-year to 0.96; the TTM figure through Jun 2026 stood at 0.96 (up 53.91% YoY), while the FY2025 annual figure was 0.95, up 31.4% from the prior year.
• Asset Utilization Ratio came in at 0.96 for Q2 2026 at Eton Pharmaceuticals, up from 0.81 in the prior quarter.
• In the past five years, Asset Utilization Ratio ranged from a high of 1.1 in Q1 2024 to a low of 0.48 in Q1 2022.
• Average Asset Utilization Ratio over 5 years is 0.83, with a median of 0.81 recorded in 2025.
• Year-over-year, Asset Utilization Ratio soared 88.15% in 2023 and sank 44.99% in 2025.
• Over 5 years, Asset Utilization Ratio stood at 0.81 in 2022, then climbed by 23.23% to 1.0 in 2023, then tumbled by 30.33% to 0.7 in 2024, then increased by 16.7% to 0.81 in 2025, then grew by 18.59% to 0.96 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.96 in Q2 2026, 0.81 in Q4 2025, and 0.68 in Q3 2025.